SURMODICS INC — Director's Dealing 2021

Nov 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2021-11-01

Reporting Person: Maharaj Gary R (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-01	Common Stock	S	5800	$54.6302	Disposed	147011	Direct
2021-11-01	Common Stock	S	200	$55.245	Disposed	146811	Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021.

F2: Reflects the weighted average price of 5,800 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 1, 2021 with sale prices ranging from $54.23 to $55.17 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reflects the weighted average price of 200 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 1, 2021 with sale prices ranging from $55.23 to $55.26 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.